GF Fund Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

GF Fund Management’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.5K	Sell	3,452 -184	-5%	-$709	﹤0.01%	508
2026 Q1	$12.8K	Buy	3,636 +440	+14%	+$1.8K	﹤0.01%	538
2025 Q4	$10.8K	Sell	3,196 -191	-6%	-$496	﹤0.01%	567
2025 Q3	$4.44K	Sell	3,387 -584	-15%	-$604	﹤0.01%	612
2025 Q2	$2.85K	Hold	3,971	–	–	﹤0.01%	644
2025 Q1	$5.84K	Buy	3,971 +611	+18%	+$1.46K	﹤0.01%	615
2024 Q4	$14.9K	Buy	+3,360	New	+$13.6K	﹤0.01%	498

Other funds holding IRWD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

GF Fund Management's IRWD Position: Q2 2026 in Review

GF Fund Management reduced its Ironwood Pharmaceuticals (IRWD) stake by 5.1% in Q2 2026, selling an estimated $709 and leaving 3,452 shares worth $14.5K. The position accounts for ﹤0.01% of the portfolio, ranked #508.

GF Fund Management first reported a position in IRWD in Q4 2024 and has held it in 7 quarters since. The position peaked at $14.9K in Q4 2024. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

GF Fund Management held 3,452 shares of Ironwood Pharmaceuticals worth $14.5K as of Q2 2026.
GF Fund Management sold 184 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $709.
Ironwood Pharmaceuticals made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #508 holding.
GF Fund Management first reported a position in Ironwood Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
GF Fund Management's Ironwood Pharmaceuticals position peaked at $14.9K in Q4 2024.
212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.